SciSparc (SPRC)

• Market cap: $26.4M
• 1 day: 7.34%
• 5 days: 2.96%
• 1 month: 0.91%
• 3 months: -64.5%
• 6 months: -72.3%
• Year to date: -55.87%
• 1 year: -91.05%
• 5 years: -99.98%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Employees: 2